Triethylenetetramine API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Located in:

United States

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Producer

Produced in:

Unknown

Established in: 1944

MOQ: -

Employees: 4,000

14 international API plant sites

Portfolio of 350+ APIs

Teva is among the world’s largest generic drug/API manufacturers

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies quickly

Located in:

Japan
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • JDMF

  • CoA

Contact supplier

Replies slower than most

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Triethylenetetramine API 112-24-3?

Description:
Here you will find a list of producers, manufacturers and traders of Triethylenetetramine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Triethylenetetramine 
Synonyms:
Trien , TETA , Trientine  
Cas Number:
112-24-3 
DrugBank number:
DB06824 
Unique Ingredient Identifier:
SJ76Y07H5F

About Triethylenetetramine

What makes Triethylenetetramine unique? Triethylenetatramine (TETA) is a highly selective divalent Cu(II) chelator and orphan drug that revereses copper overload in tissues. Its salt form, trientine (triethylenetetramine dihydrochloride or 2,2,2-tetramine) was introduced in 1969 as an alternative to D-penicillamine. It consists of a polyamine-like structure different from D-penicillamine, as it lack sulfhydryl groups. It was previously approved by FDA in 1985 as second-line pharmacotherapy for Wilson's disease.

Although penicillamine treatment is believed to be more extensive, TETA therapy has been shown to be an effective initial therapy, even with patients with decompensated liver disease at the outset, and prolonged TETA treatment is not associated with adverse effects as expected in penicillamine treatment. Its clinical applications on cancer, diabetes mellitus, Alzheimer's disease and vascular demetia are being studied.

Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.

Triethylenetetramine is a type of Chelating agents


Chelating agents are a crucial subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a vital role in various medicinal applications. These agents possess a unique ability to form coordination complexes with metal ions, thus facilitating the removal of these ions from biological systems. Chelation is the process of binding metal ions tightly through multiple coordination bonds, forming stable chelates.

Chelating agents find widespread application in pharmaceutical formulations, particularly in the treatment of heavy metal poisoning and metal-related diseases. They act by chelating toxic metal ions, such as lead, mercury, or arsenic, and enhancing their elimination from the body through urine or feces.

In addition to their metal chelation properties, these agents offer several therapeutic benefits. They can improve the bioavailability and stability of pharmaceutical formulations by complexing with metal ions that may otherwise degrade or interact with other compounds in the formulation. Chelation therapy also shows promise in the treatment of certain cardiovascular diseases, as it can help remove calcium deposits from arterial walls.

Commonly used chelating agents in pharmaceuticals include ethylenediaminetetraacetic acid (EDTA), dimercaprol (BAL), and deferoxamine. These agents are carefully selected based on their specific chelating properties and safety profiles.

Overall, chelating agents are indispensable in the pharmaceutical industry due to their ability to effectively bind and remove toxic metal ions from the body. Their diverse applications make them a crucial component in the formulation of medicines, offering therapeutic benefits and improved drug delivery.


Triethylenetetramine (Chelating agents), classified under Others


The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.

Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.

The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.

Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.

In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.



Triethylenetetramine manufacturers | traders | suppliers

We have 6 companies offering Triethylenetetramine produced in 3 different countries.

Get in contact with the supplier of your choice:

  • NAVINTA from United States, product country of origin Unknown
  • Teva API from Israel, product country of origin Unknown
  • Sumitomo Chemical from Japan, product country of origin Japan
  • Emcure Pharma from India, product country of origin India
  • Biophore India from India, product country of origin India
  • MSN Organics from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.